TVGN•benzinga•
Tevogen Reaffirms Its Top-Line Revenue Forecast For Its Oncology Pipeline, Projecting $1B In Revenue In Its Launch Year And A Cumulative 5-Year Estimate Of Between $10B-$14B
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 28, 2025 by benzinga